N2004-04: Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium
New Approaches to Neuroblastoma Therapy Consortium
Celgene
Montefiore Medical Center
AbbVie
GlaxoSmithKline
Takeda
National Cancer Institute (NCI)
Seagen Inc.
University of Chicago
Eisai Inc.
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Abbott
Abbott